logo

Notice Of Intent To Award A Sole Source Contract To Irubis Gmbh

Sector: Commercial • Location: Silver Spring, Maryland, United States of America

Source: SAM.gov

Tender
Special Notice

The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price commercial Purchase Order (PO) to IRUBIS GmbH, Bayerstrasse 85A, Munchen, Bavaria 80335, Germany for the Purchase of a MONIPA_1 Protein Concentration Analyzer. Please review the attached Intent to Sole Source FDA-133409 document for more information.

Status
Prospective
Sector
Commercial, Manufacturing (Industrial)
Location
Silver Spring, Maryland, United States of America
Updated
3 Nov 2026
Source
SAM.gov

ConstructChat

Ask ConstructChat about Notice Of Intent To Award A Sole Source Contract To Irubis Gmbh

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “Notice Of Intent To Award A Sole Source Contract To Irubis Gmbh” is a tender record in Taiyo, linked to the Commercial sector. It is issued for works, goods, or services related to Silver Spring, Maryland, United States of America.

Participants

Not available for this record.

Status

Original status

special notice

Taiyo status

Prospective

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price commercial Purchase Order (PO) to IRUBIS GmbH, Bayerstrasse 85A, Munchen, Bavaria 80335, Germany for the Purchase of a MONIPA_1 Protein Concentration Analyzer. Please review the attached Intent to Sole Source FDA-133409 document for more information.

Original sector

Not Identified

Location

Country

United States of America (USA)

State

Maryland

City

Silver Spring

Source

Source

SAM.gov

URL

More Details

Record type

Tender

Sector

Commercial, Manufacturing (Industrial)

Article published date

2026-06-02

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender